The IP pipeline your licensing team has never seen.
Lattice indexes every U.S. pharma patent — claims, abstracts, and assignment data — and ranks results by how closely they match what you’re looking for.
“A selective dual agonist of GLP-1 and GIP receptors comprising a fatty-acid acyl moiety conferring once-weekly subcutaneous dosing in human subjects with type 2 diabetes mellitus…”
“A recombinant bispecific binding molecule that simultaneously engages programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor A (VEGF-A) for the treatment of advanced solid tumors…”
“An ionizable cationic lipid composition encapsulating in vitro-transcribed messenger RNA encoding tumor-associated neoantigens, formulated as a lipid nanoparticle for intramuscular administration…”
Patent search rewards whoever guesses the right keywords.
That leaves real value buried — assets described in different language, filed under an adjacent CPC code, or held by an owner you weren’t watching.
Lattice searches by meaning. Every claim, abstract, and description is embedded and ranked by semantic relevance, with the current owner and licensing status on every result.
Three steps from pipeline gap to licensable IP.
Query in plain language, claim text, or structured filters. Lattice understands all three.
Describe your pipeline gap
Query by therapeutic area, mechanism, target, or claim language — natural language or structured filters work the same way.
Lattice surfaces ranked IP
Patent- and claim-level results scored by semantic relevance — each with current-owner and licensing-status signals, across every pharma assignee in the corpus.
Route to the current owner
Each result lists the current owner and inventor, with the licensing-status read. Follow up via the patent number — in-platform introductions land in 2026.
Every patent, connected to your pipeline.
Lattice doesn’t just return a list — it maps the relationships between your technology areas, the approaches that address them, the institutions that own them, and the patents that link it all. Hover any node to trace its connections.
Not another catalog. Not another consultant.
Catalogs show landscapes; Lattice shows licensable patents. Brokers work mandates; Lattice runs continuously across the same pharma corpus, every day.
Lattice vs. Catalogs
Lattice vs. Brokers
Search the pharma IP your competitors can’t surface.
We’re onboarding a small group of licensing, BD, and IP teams for early access — semantic search across every U.S. pharma patent, with current-owner and licensing-status data on each result.